This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(MedPage Today) -- The efficacy of catheter ablation for heartfailure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with conventional rate or rhythm.
A BMJ study out of Denmark provided alarming new insights into atrial fibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFibheartfailure and stroke prevention. Danish people who didn’t have AFib at baseline (45-95yrs, 48yr avg, 51.7% in 2000-2010 to 30.9%
A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heartfailure.
Novartis initially prioritized its treatments for heartfailure and plaque-clogged arteries when it spun-off abelacimab but continued to monitor the Factor XI race, leading to its choice to take the baton back from Anthos.
healthcare providers can now detect Low EF, a key heartfailure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heartfailure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2
At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of Atrial Fibrillation (AFib). Ultrahuman Ring AIR is the first smart ring in the world to offer AFib detection. AFib is the most common type of irregular heart rhythm or arrhythmia.
Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased risk of heartfailure (HF) hospitalization and atrial fibrillation (AFib) recurrence.
Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heartfailure, making it essential to understand its causes, symptoms, and AFib treatment options. What is Atrial Fibrillation?
History of prior heartfailure (HF) was found to influence prognostic implications of atrial fibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as presenting rhythm differentiating outcome.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heartfailure.
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). Today, approximately 8 million Europeans over the age of 65 are living with AFib, a number expected to double over the next 30 years.
Statins are one of the most-prescribed drug classes in the world, but there’s still little data on their heartfailure benefits, especially for HFpEF patients. The two major RCTs evaluating statins as a heartfailure treatment (CORONA and GISSI-HF) didn’t show significant benefits, although they mainly focused on HFrEF patients.
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
Atrial fibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heartfailure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
Catheter Ablation for Atrial Fibrillation (AFib) in heartfailure is now a class I indication for patients with heartfailure. Evidence supports the relationship between obesity and the incidence and recurrence of Afib.
Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AFib) did not reduce the recurrence of AFib at one year, based on findings from the SUPPRESS-AF trial presented at ESC Congress 2024 in London.
The combined solutions are expected to enhance performance and streamline workflows for electrophysiologists during catheter ablation procedures to treat atrial fibrillation , AFib. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.
Nearly 50% of patients with AFib have comorbid obstructive sleep apnea (OSA), and 75% of OSA patients report some form of arrhythmia. Untreated OSA increases likelihood of poor outcomes for AFib patients including failed treatment, heartfailure, and sudden cardiac death.
While the holidays themselves can’t cause a heart attack , certain things people do during the hectic, festive season may stress their heart health more than they realize. Plus, these stressors can increase the risk of heart attack, stroke or retention of extra fluid and heartfailure , explains Dr. Tarditi.
CardioSignal has already developed digital biomarkers for AFib and heartfailure, while more solutions could be on the way for aortic stenosis, coronary artery disease, and pulmonary artery hypertension.
A swimmer, hiker, and martial artist, you’d never guess 64-year-old Trisha McLaughlin struggled with an irregular heartbeat, congestive heartfailure, and has undergone a number of heart procedures.
Catheter ablation (CA) for atrial fibrillation (AF) and heartfailure with reduced ejection fraction <40% (HFrEF) is associated with improved outcomes. The patient characteristics, AF effect on quality-of-life questionnaire (AFEQT), and ablation strategies performed remains uncertain in those with and without HFrEF.
It is estimated that more than 12 million people in the United States will have Atrial Fibrillation, or AFib in 2030. It is one of the most commonly diagnosed heart conditions and is characterized by an irregular heartbeat or rhythm, known as arrhythmia.
Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and risk factors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrial fibrillation (AFib) ablation in patients with heartfailure with (..)
It’s well known that heart disease is the U.S.’s Heart Disease in 2050 – The AHA warned of massive heart disease increases by 2050, spanning CVD (+60%), diabetes (+100%), obesity (+70%), hypertension (+44%), heartfailure (+66%), and stroke (+100%). trillion, representing 4.6% If applied across the U.S.,
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).
Atrial fibrillation often shortened to AFib is an irregular and often rapid heart rhythm that can lead to serious health complications. If you or someone you know is living with AFib, understanding the condition and how to prevent attacks is crucial. What Is AFib? How Do You Know If You Have AFib?
In July 2023 Eko Health announced a partnership with Japanese Life Sciences company Astellas Pharma to develop a non-invasive device Digital Therapeutics (DTx) solution for heartfailure patients. Fertile Partnerships Ongoing research partnerships have driven much of recent developments seen in the market.
Abstract Introduction Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heartfailure, and increased mortality. Results/Observation Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity.
. = My Comment by K EN G RAUER, MD ( 3/15 /2023 ): = I found today’s case highly instructive in highlighting a number of important aspects regarding the presentation and initial treatment of a patient who presents to the ED with new AFib. I focus my comment on a few additional aspects regarding new AFib.
(Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists. American College of Cardiology Journal) Are you thinking of stopping your antiplatelet medication too soon after angioplasty? Reconsider your position.
It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. 7 Atrial fibrillation has a significant impact on people’s lives.
She was known to have a history of poorly controlled COPD, AFib, and multivessel coronary disease. It is infrequently encountered, but still utilized as means of AV nodal suppression, or enhanced inotropy – which makes it ideal when a patient has both systolic heartfailure and Atrial Fibrillation.
At the time, it seemed that virtually all cardiac patients with chronic AFib or heartfailure were on this medication. IV Digoxin may begin to slow the ventricular response of AFib or AFlutter sooner than many clinicians realize. Smith — the choice of IV Digoxin was appropriate and effective in today's case.
C linical P oints R egarding E CG # 1 : We are told that the patient is a middle-aged woman and that she previously had been in AFib with LBBB. While I agree that AFib + complete AV block is the most likely rhythm diagnosis I'd like to see additional monitoring strips to be sure. Has this patient been cathed?
Cardioversion is used to correct abnormal heart rhythms, also known as arrhythmias. When your heart beats too quickly, too slow, or irregularly, it can affect your blood flow and lead to severe complications like stroke or heartfailure. Cardioversions can help “reset” your heart rhythm to its regular pattern.
OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heartfailure and other serious cardiovascular conditions. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D.,
Slow VT below the detection rate of the ICD lead to worsening heartfailure and low stroke volume. Post conversion of VT the patient had low output cardiac failure and became unstable and hypoperfused. The patient also has a history of AFib and HFmrEF ( = H eart F ailure with M inimally- R educed E jection F raction ).
heartfailure). Depending on who you talk to, we could be headed towards a completely new anticoagulation standard of care. Prevention & Detection – Boosted by GLP-1 obesity buzz and the fact that cardiovascular outcome trends have been headed in the wrong direction, AHA 2023 placed a greater focus on prevention.
PSM components were age, gender, race, PPI use, anti-platelets, hypertension, coronary artery disease, heartfailure, COPD, and CKD. We compared the risk of stroke, GIB, and mortality in 5 years.Results:A total of 19,427 patients with UGIB who have AFIB received oral apixaban were identified.
LVH is a common etiology of heartfailure with preserved ejection fraction, as it may results in a stiff ventricle with poor diastolic relaxation. WPW Cardiac arrhythmias ( especially AFib ). LVH can have very thick-walled ventricles and a correspondingly small LV cavity. Abnormal ST-T wave abnormalities.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content